How many employees work at Vivoryon Therapeutics?
Vivoryon Therapeutics NV (VVY) has approximately 16 total employees worldwide as of March 2026, according to Revelio Labs workforce intelligence data. Vivoryon Therapeutics’s total headcount has declined 8.1% from 17 employees in 2023 to 16 in 2026.
About Vivoryon Therapeutics’s Workforce
Vivoryon Therapeutics NV (VVY) is a Biotech and Healthcare Services company that employs 16 people worldwide as of March 2026. It is the 8th-largest by headcount among its peers. Founded in 2001, the company is headquartered in Germany and trades on the Euronext Amsterdam.
Vivoryon Therapeutics's workforce has declined 8.1% from 2023 to 2026, though it is up 1.4% year over year in 2026. It fell to a low of 14 in 2024 Q3 before recovering. Its workforce is concentrated most in Western Europe (94.3%), followed by Southeast Asia (5.7%).
Vivoryon Therapeutics's functional groups are Finance and Operations (43.6%), Engineering (33.8%), and Sales and Marketing (22.6%), with Finance and Operations growing fastest (up 4.0%). The average salary is $176,951, highest in Western Europe at a median of $120,000, up 17.8% year over year in 2026.
Overall employee sentiment is positive and broadly stable.
Sourced from Revelio Labs workforce data.
- Ticker
- Euronext Amsterdam: VVY
- Headquarters
- Germany
- Founded
- 2001
- Industry
- Biotech and Healthcare Services
- Employees
- 16
- YoY
- +1.4% (+2)
As of March 2026
Vivoryon Therapeutics workforce metrics
Unlock hiring rate, attrition rate, and 12 additional workforce metrics for Vivoryon Therapeutics. Compare to peers, export the dataset, and access the full quarterly history.
Unlock MetricsVivoryon Therapeutics Annual Employee Count (2023-2026)
- Vivoryon Therapeutics had 16 employees in 2026, a 1.4% increase (+2) from 2025.
- Vivoryon Therapeutics had 16 employees in 2025, a 1.4% increase (+2) from 2024.
- Vivoryon Therapeutics had 14 employees in 2024, a 16.7% decline (-6) from 2023.
- Vivoryon Therapeutics had 20 employees in 2023, a 8.9% increase (+3) from 2022.
Vivoryon Therapeutics's total workforce has grown from 14 employees in 2024 to 16 in 2026. Vivoryon Therapeutics's headcount peaked at 20 in 2023 before declining in 2024 and recovering through 2025 and 2026.
Vivoryon Therapeutics NV quarterly employee count
| Year | Qtr | Employees | YoY Change | YoY % |
|---|---|---|---|---|
| 2026 | Q1 | 16 | +2 | +1.4% |
| 2025 | Q4 | 16 | +2 | +1.4% |
| 2025 | Q3 | 16 | +2 | +8.0% |
| 2025 | Q2 | 16 | -1 | +7.3% |
| 2025 | Q1 | 14 | -3 | +0.0% |
| 2024 | Q4 | 14 | -6 | -16.7% |
| 2024 | Q3 | 14 | -3 | -11.5% |
| 2024 | Q2 | 17 | +0 | -10.4% |
| 2024 | Q1 | 17 | +0 | -10.4% |
| 2023 | Q4 | 20 | +3 | +8.9% |
| 2023 | Q3 | 17 | +1 | +3.5% |
| 2023 | Q2 | 17 | +1 | +3.4% |
See Vivoryon Therapeutics's complete headcount history, including quarterly breakdowns.
Get the DataVivoryon Therapeutics Employee Count by Region (2026)
Western Europe accounts for the largest share of Vivoryon Therapeutics's global workforce with approximately 94% of total employees, followed by Southeast Asia.
Vivoryon Therapeutics employees by region
| Region | Employees | % of Total |
|---|---|---|
| Western Europe | 15 | 94.3% |
| Southeast Asia | 1 | 5.7% |
Drill into city-level data, hiring trends by region, and historic geographic shifts.
Unlock Geographic DataVivoryon Therapeutics Employee Count by Department (2026)
Vivoryon Therapeutics's employee groups are Finance and Operations (43.6%), Engineering (33.8%), and Sales and Marketing (22.6%).
Vivoryon Therapeutics employees by department
| Department | Employees | % of Total |
|---|---|---|
| Finance and Operations | 7 | 43.6% |
| Engineering | 5 | 33.8% |
| Sales and Marketing | 4 | 22.6% |
Compare Vivoryon Therapeutics's department mix to industry peers.
See Full DataVivoryon Therapeutics Employee Salary by Region (2026)
Vivoryon Therapeutics's average employee salary is $176,951 globally. Employees in Western Europe receive the highest compensation.
Vivoryon Therapeutics median employee salary by region (USD)
| Region | Median Salary |
|---|---|
| Western Europe | $120,000 |
Unlock salary by role, level, and city — and compare to Vivoryon Therapeutics's industry peers.
Unlock Salary DataVivoryon Therapeutics Employee Sentiment (2026)
Revelio Labs tracks employee sentiment across Vivoryon Therapeutics's workforce based on public professional data. Overall sentiment is positive and has held steady year over year in 2026.
Overall
Unlock the full sentiment breakdown by department, tenure, and trend over time.
Unlock SentimentSimilar Companies
Similar Biotech and Healthcare Services Companies by Employee Count
Frequently Asked Questions About Vivoryon Therapeutics
- How fast is Vivoryon Therapeutics growing?
- In 2026, Vivoryon Therapeutics's headcount grew 1.4% to 16 employees, up from 14 in 2025.
- See the full headcount history
- Where are Vivoryon Therapeutics employees located?
- Most Vivoryon Therapeutics employees are based in Western Europe (94.3% of headcount), followed by Southeast Asia.
- Explore where the workforce is based
- What is the average salary at Vivoryon Therapeutics?
- The average employee salary at Vivoryon Therapeutics is approximately $177k per year.
- Analyze the salary distribution
- When was Vivoryon Therapeutics founded and where is it headquartered?
- Vivoryon Therapeutics was founded in 2001 and is headquartered in Germany.
- Compare Vivoryon Therapeutics to industry peers
Speak with a workforce expert about Vivoryon Therapeutics.
Book a DemoSee something that doesn't look right? Reach out and our team will review it.